Postdoc Profile: Hannah Twarkowski, PhD
Hannah Twarkowski, PhD, is a postdoctoral fellow in the lab of Amar Sahay, PhD, investigating how neurons can write, update and store memories.
Research Roundup: Genetic Protection from Alzheimer’s Disease, Football Players and Heart Health, and More
Recent research news from the Mass General Research Institute, including insights into genetic protection from Alzheimer’s disease, heart health and more.
Alzheimer’s Disease Expert Says Future Treatment Success Will Require a Shift in Strategy and Timing
Rudy Tanzi, PhD, believes the key to treating Alzheimer’s disease will be earlier detection and treatment guided by individual risk factors and family history.
From the Gut to the Brain: Exploring a New Pathway for the Onset of Alzheimer’s Disease
A research project led by Massachusetts General Hospital’s Deepak Vijaya Kumar, PhD, will seek to untangle the connections between microbes in the gut and the onset of Alzheimer’s disease.
Do Lifestyle Factors Such as Stress Affect the Onset and Progression of Alzheimer’s Disease?
A team of researchers from Massachusetts General Hospital are exploring the role of lifestyle factors such as stress in the onset and progression of Alzheimer’s disease.
Regulating Microglia’s Three Roles May Be the Key to Managing Inflammation in the Brain
Experts have long thought of microglia as the immune cells of the brain because they support and defend cells within the central nervous system. To help describe their various functions, scientists have classified microglia into three different roles: sentinels, warriors and nurturers. But what happens to the brain when these microglia aren’t doing their job […]
Gatchel Untangles the Causes of Mood and Anxiety Symptoms and Loss of Brain Function in Aging Populations
Mass General geriatric psychiatrist Jennifer Gatchel MD, PhD, is working to unravel the connections between mental illness and the onset of Alzheimer’s disease.
How a 3D Model of Alzheimer’s Disease is Providing New Hope in the Search for Treatments
Reigning in Alzheimer’s disease continues to be a challenge — more than 10 million families are affected by this degenerative neurological disease, and the number of patients dying from the disease has increased 68 percent since 2010. In the past decade, attempts at developing drugs to slow or halt the progression of Alzheimer’s disease have […]